Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,279

The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.

Humanized mice in translational biomedical research

Shultz, Leonard D., Ishikawa, Fumihiko, Greiner, Dale L.·2007·Nature Reviews Immunology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nri2017

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 24

  1. Lowry, P. A. et al. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients. Biol. Blood Marrow Transplant. 2, 15–23 (1996).
  2. Zanjani, E. D., Almeida-Porada, G. & Flake, A. W. Retention and multilineage expression of human hematopoietic stem cells in human–sheep chimeras. Stem Cells 13, 101–111 (1995). · doi:10.1002/stem.5530130202
  3. Clutterbuck, R. D. et al. Studies on the development of human acute myeloid leukaemia xenografts in immune-deprived mice: comparison with cells in short-term culture. Leuk. Res. 9, 1511–1518 (1985). · doi:10.1016/0145-2126(85)90044-x
  4. Schoeberlein, A. et al. Engraftment kinetics of human cord blood and murine fetal liver stem cells following in utero transplantation into immunodeficient mice. Stem Cells Dev. 13, 677–684 (2004). · doi:10.1089/scd.2004.13.677
  5. Cohen-Haguenauer, O. et al. In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients. Proc. Natl Acad. Sci. USA 103, 2340–2345 (2006). · doi:10.1073/pnas.0510613103
  6. Matsumura, T. et al. Functional CD5+ B cells develop predominantly in the spleen of NOD/SCID/γcnull (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34+ cells. Exp. Hematol. 31, 789–797 (2003). · doi:10.1016/s0301-472x(03)00193-0
  7. Camacho, R. E. et al. Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice. Cell. Immunol. 232, 86–95 (2004). · doi:10.1016/j.cellimm.2005.02.003
  8. Ifversen, P. & Borrebaeck, C. A. SCID-hu-PBL: a model for making human antibodies? Semin. Immunol. 8, 243–248 (1996). · doi:10.1006/smim.1996.0030
  9. Murphy, W. J., Taub, D. D. & Longo, D. L. The huPBL-SCID mouse as a means to examine human immune function in vivo. Semin. Immunol. 8, 233–241 (1996). · doi:10.1006/smim.1996.0029
  10. Tary-Lehmann, M., Lehmann, P. V., Schols, D., Roncarolo, M. G. & Saxon, A. Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras. J. Exp. Med. 180, 1817–1827 (1994). · doi:10.1084/jem.180.5.1817
  11. Greiner, D. L. & Shultz, L. D. in NOD Mice and Related Strains: Research Applications in Diabetes, AIDS, Cancer and Other Diseases (eds Leiter, E. & Atkinson, M.) 173–203 (Landes Bioscience, Austin, 1998).
  12. McCune, J. et al. The SCID-hu mouse: a small animal model for HIV infection and pathogenesis. Annu. Rev. Immunol. 9, 399–429 (1991). · doi:10.1146/annurev.iy.09.040191.002151
  13. Davis, P. H. & Stanley, S. L. Jr Breaking the species barrier: use of SCID mouse–human chimeras for the study of human infectious diseases. Cel. Microbiol. 5, 849–860 (2003). · doi:10.1046/j.1462-5822.2003.00321.x
  14. Kneteman, N. M. et al. Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application. Hepatology 43, 1346–1353 (2006). · doi:10.1002/hep.21209
  15. Morosan, S. et al. Liver-stage development of Plasmodium falciparum, in a humanized mouse model. J. Infect. Dis. 193, 996–1004 (2006). · doi:10.1086/500840
  16. Moreno, A. et al. The course of infections and pathology in immunomodulated NOD/LtSz-SCID mice inoculated with Plasmodium falciparum laboratory lines and clinical isolates. Int. J. Parasitol. 36, 361–369 (2006). · doi:10.1016/j.ijpara.2005.10.012
  17. Lapenta, C. et al. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice. Int. Immunol. 17, 469–475 (2005). · doi:10.1093/intimm/dxh226
  18. Mosier, D. E. Viral pathogenesis in hu-PBL-SCID mice. Semin. Immunol. 8, 255–262 (1996). · doi:10.1006/smim.1996.0032
  19. Davis, L. S. et al. Inflammation, immune reactivity, and angiogenesis in a severe combined immunodeficiency model of rheumatoid arthritis. Am. J. Pathol. 160, 357–367 (2002). · doi:10.1016/s0002-9440(10)64379-9
  20. Pilarski, L. M. & Belch, A. R. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34+ hematopoietic progenitors. Clin. Cancer Res. 8, 3198–3204 (2002).
  21. Flavell, D. J. et al. The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma. Br. J. Haematol. 134, 157–170 (2006). · doi:10.1111/j.1365-2141.2006.06155.x
  22. Chalandon, Y. et al. BCR–ABL-transduced human cord blood cells produce abnormal populations in immunodeficient mice. Leukemia 19, 442–448 (2005). · doi:10.1038/sj.leu.2403650
  23. Ma, N. et al. Umbilical cord blood cell transplantation for myocardial regeneration. Transplant Proc. 38, 771–773 (2006). · doi:10.1016/j.transproceed.2006.01.061
  24. Stamm, C., Liebold, A., Steinhoff, G. & Strunk, D. Stem cell therapy for ischemic heart disease: beginning or end of the road? Cell Transplant. 15 (Suppl. 1), 47–56 (2006). · doi:10.3727/000000006783982313

Cited by

See all 1,279

Metadata

Authors
Shultz, L. D., Ishikawa, F., & Greiner, D. L.
Venue
Nature Reviews Immunology
Published
2007-02
Volume
7
Issue
2
Pages
118-130
ISSN
  • 1474-1733 (ISSN-L)
  • 1474-1741
OpenAlex
W2021586066
Cited by
1,279
References
115
FWCI
5.07
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.